SK Biopharmaceuticals Co., Ltd. (KRX:326030)

SK Biopharmaceuticals Statistics

Total Valuation

KRX:326030 has a market cap or net worth of KRW 10.95 trillion. The enterprise value is 10.76 trillion.

Market Cap	10.95T
Enterprise Value	10.76T

Important Dates

The last earnings date was Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:326030 has 78.31 million shares outstanding.

Current Share Class	78.31M
Shares Outstanding	78.31M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	12.95%
Float	28.07M

Valuation Ratios

The trailing PE ratio is 34.16 and the forward PE ratio is 44.12. KRX:326030's PEG ratio is 5.25.

PE Ratio	34.16
Forward PE	44.12
PS Ratio	16.21
PB Ratio	15.88
P/TBV Ratio	16.46
P/FCF Ratio	76.53
P/OCF Ratio	74.89
PEG Ratio	5.25

Enterprise Valuation

The stock's EV/EBITDA ratio is 61.29, with an EV/FCF ratio of 75.20.

EV / Earnings	33.57
EV / Sales	15.93
EV / EBITDA	61.29
EV / EBIT	68.06
EV / FCF	75.20

Financial Position

The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.07.

Current Ratio	2.43
Quick Ratio	1.84
Debt / Equity	0.07
Debt / EBITDA	0.23
Debt / FCF	0.35
Interest Coverage	21.99

Financial Efficiency

Return on equity (ROE) is 58.15% and return on invested capital (ROIC) is 19.35%.

Return on Equity (ROE)	58.15%
Return on Assets (ROA)	13.73%
Return on Invested Capital (ROIC)	19.35%
Return on Capital Employed (ROCE)	25.91%
Revenue Per Employee	2.75B
Profits Per Employee	1.30B
Employee Count	246
Asset Turnover	0.75
Inventory Turnover	0.31

Taxes

Income Tax	-158.26B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +39.94% in the last 52 weeks. The beta is 0.83, so KRX:326030's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	+39.94%
50-Day Moving Average	114,910.00
200-Day Moving Average	105,033.00
Relative Strength Index (RSI)	76.03
Average Volume (20 Days)	430,613

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:326030 had revenue of KRW 675.41 billion and earned 320.47 billion in profits. Earnings per share was 4,092.19.

Revenue	675.41B
Gross Profit	641.58B
Operating Income	198.31B
Pretax Income	148.67B
Net Income	320.47B
EBITDA	215.77B
EBIT	198.31B
Earnings Per Share (EPS)	4,092.19

Balance Sheet

The company has 256.16 billion in cash and 49.37 billion in debt, giving a net cash position of 206.79 billion or 2,640.59 per share.

Cash & Cash Equivalents	256.16B
Total Debt	49.37B
Net Cash	206.79B
Net Cash Per Share	2,640.59
Equity (Book Value)	689.46B
Book Value Per Share	8,591.11
Working Capital	378.28B

Cash Flow

In the last 12 months, operating cash flow was 146.18 billion and capital expenditures -3.13 billion, giving a free cash flow of 143.05 billion.

Operating Cash Flow	146.18B
Capital Expenditures	-3.13B
Free Cash Flow	143.05B
FCF Per Share	1,826.65

Margins

Gross margin is 94.99%, with operating and profit margins of 29.36% and 47.45%.

Gross Margin	94.99%
Operating Margin	29.36%
Pretax Margin	22.01%
Profit Margin	47.45%
EBITDA Margin	31.95%
EBIT Margin	29.36%
FCF Margin	21.18%

Dividends & Yields

KRX:326030 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.93%
FCF Yield	1.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:326030 has an Altman Z-Score of 15.51 and a Piotroski F-Score of 6.

Altman Z-Score	15.51
Piotroski F-Score	6